Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques in Pregnant Females

Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques on Neuropathic Pain, Knee Range of Motion and Quality of Life in Pregnant Females

The rationale of this study is to provide empirical evidence regarding the efficacy and safety of neural mobilization in pregnant women with meralgia paresthetica. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating neural mobilization into the management of this condition during pregnancy. Focusing on the impact of neural mobilization and muscle energy techniques on both neuropathic pain and quality of life aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Study Overview

• Status: Completed
• Conditions: Meralgia Paresthetica
• Intervention / Treatment: Other: Group A; Other: Experimental Group B

Detailed Description

The literature gap of the study is that upto our knowledge, there is little or no evidence found in previous researches on the combined effects of lateral femoral cutaneous nerve mobilization in combination with MET in pregnant females. Secondly no quantitative measurement as range of motion with goniometer has been yet studied

• Study Type: Interventional
• Enrollment (Actual): 48
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Lahore, Punjab, Pakistan
      • Ghurki Hospital
    • Lahore, Punjab, Pakistan
      • Ghurkhi Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Age ranges from 18 to 40 years
• Body mass index ≥25kg/m2.
• Pregnant females in third trimester diagnosed with myalgia paraesthetica.
• Multigravida pregnant females
• Patients will be screened through Prone Knee Bend (PKB) test for femoral nerve compression.
• Positive pelvic compression test(1)

Exclusion Criteria:

• Those having other entrapment syndromes or radicular symptoms
• Motor weakness
• Having a history or ongoing cancerous proliferation
• Active infection

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: GROUP B	Other: Experimental Group B; It involves 24 patients who had received the neural mobilization described above along with traditional physical therapy that does not involve muscular energy techniques. The treatment took place in the outpatient physical therapy department and lasted around thirty minutes in total
Experimental: group A; Lateral Femoral cutaneous nerve mobilization with muscle energy techniques	Other: Group A; It consists of 24 patients who were assessed by prone knee bend (PKB) test and knee range of motion was measured by goniometer. In addition to traditional physical therapy and muscle energy procedures, patients in this group received neural mobilization. The patient laid on their side with their knee bent to a 90-degree angle and the affected side looking up while neural mobilization was carried out. The therapist then performed the technique by abducting and extending the patient's hip. Five repetitions of the nerve stretch were performed, each with a 10-second hold and a 5-second rest in between. METs were implemented in two positions using post-isometric relaxation (PIR): In this initial posture, the patient laid on their back with the affected leg just over the bed's edge. With one hand, the physiotherapist stood facing the affected side and pressed the contralateral ASIS to keep the patient from rolling off the bed. The therapist, however, simultaneously grabbed the femur dist

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
quality of life is assessed by QOL questioner	EQ-5D is used to measure quality of life	at base line pre intervention, at the end of 4th week post intervention
Knee range of motion is used to measure ROM	measured by goniometer	at base line pre intervention, at the end of 4th week post intervention
neuropathic pain	The Neuropathic Pain Scale (NPS) is a tool used to assess the specific qualities of pain associated with neuropathic pain. It helps differentiate neuropathic pain from other types of pain by evaluating different pain sensations and their intensity. The NPS consists of 10 items, each rated on a scale of 0 to 10, where 0 is "no pain" and 10 is the "worst imaginable pain".	at base line pre intervention, at the end of 4th week post intervention

Collaborators and Investigators

• Sponsor: Riphah International University
• Investigators: Principal Investigator: Iqra abdul ghafoor, PPDPT, Riphah International University

Study record dates

Study Major Dates

• Study Start (Actual): December 23, 2024
• Primary Completion (Actual): May 15, 2025
• Study Completion (Actual): May 15, 2025

Study Registration Dates

• First Submitted: December 20, 2024
• First Submitted That Met QC Criteria: December 20, 2024
• First Posted (Actual): December 27, 2024

Study Record Updates

• Last Update Posted (Actual): July 25, 2025
• Last Update Submitted That Met QC Criteria: July 21, 2025
• Last Verified: July 1, 2025

More Information

Terms related to this study

• Keywords: femoral neuropathy
• Additional Relevant MeSH Terms: Nervous System Diseases; Neuromuscular Diseases; Peripheral Nervous System Diseases; Mononeuropathies; Femoral Neuropathy
• Other Study ID Numbers: REC/00234 Mehwish

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No